LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 143

Search options

  1. Article: Regulation of prothrombinase activity by protein S.

    van 't Veer, C / Butenas, S / Golden, N J / Mann, K G

    Thrombosis and haemostasis

    1999  Volume 82, Issue 1, Page(s) 80–87

    Abstract: The independent effect of protein S as prothrombinase inhibitor has been proposed to depend ... S (300 nM) equilibrated with the prothrombinase components (factor Va, factor Xa, phospholipid ... This inhibition by protein S of prothrombinase activity is abrogated with increasing phospholipid concentrations ...

    Abstract The independent effect of protein S as prothrombinase inhibitor has been proposed to depend on binding to both coagulation factors Va and factor Xa or on the binding to phospholipid thereby limiting the phospholipid available for prothrombinase activity. In this study we show that plasma concentrations of protein S (300 nM) equilibrated with the prothrombinase components (factor Va, factor Xa, phospholipid) cause a profound inhibition at low phospholipid concentrations (approximately 0.2 microM). This inhibition by protein S of prothrombinase activity is abrogated with increasing phospholipid concentrations. Modeling of the effect of protein S on prothrombinase based only on the reported affinity of protein S for phospholipids (Kd approximately 10(-8) M) in an equilibrium model (Clotspeed), predicted the experimentally obtained thrombin generation rates at low phospholipid in the presence of protein S based on the diminished available phospholipid binding sites for the prothrombinase components. Consistently, initial rates of prothrombinase activity are already maximally inhibited when protein S is preincubated with the phospholipid prior to the addition of factor Xa, factor Va and prothrombin. The results indicate that the order of addition of prothrombinase components and the availability of phospholipid may have a profound influence on observed effects of protein S on prothrombinase activity. All prothrombinase components (factor Xa, factor Va, phospholipid) become available during the course of the physiological thrombin generation. The effect of protein S was therefore studied on tissue factor-induced, platelet-dependent thrombin generation. Protein S delayed and inhibited the rate of thrombin generation of tissue factor-induced thrombin formation when surface is provided at physiologic concentrations using isolated platelets (2 x 10(8)/ml). In contrast, protein S hardly affected thrombin generation in this model when platelets were pre-activated with collagen. Furthermore, the observed effects of addition of protein C and thrombomodulin in the absence or presence of protein S on tissue factor-induced, platelet-dependent thrombin generation, indicate that protein S and protein C may cooperate in the regulation of prothrombinase activity through independent mechanisms.
    MeSH term(s) Blood Coagulation ; Factor Va/metabolism ; Factor Xa/metabolism ; Humans ; Protein S/chemistry ; Protein S/metabolism ; Thromboplastin/chemistry ; Thromboplastin/metabolism
    Chemical Substances Protein S ; Factor Va (65522-14-7) ; Thromboplastin (9035-58-9) ; Factor Xa (EC 3.4.21.6)
    Language English
    Publishing date 1999-07
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 518294-3
    ISSN 0340-6245
    ISSN 0340-6245
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Letter: in response to a recent article by van der Beelen et al.

    Prior, Shannon / Butenas, Saulius

    Thrombosis research

    2021  Volume 202, Page(s) 104

    Language English
    Publishing date 2021-03-23
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 121852-9
    ISSN 1879-2472 ; 0049-3848
    ISSN (online) 1879-2472
    ISSN 0049-3848
    DOI 10.1016/j.thromres.2021.03.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Circulating tissue factor in humans.

    Butenas, Saulius

    Polskie Archiwum Medycyny Wewnetrznej

    2016  Volume 126, Issue 5, Page(s) 307–308

    MeSH term(s) Humans ; Thromboplastin
    Chemical Substances Thromboplastin (9035-58-9)
    Language English
    Publishing date 2016-05-31
    Publishing country Poland
    Document type Journal Article ; Comment
    ZDB-ID 123500-x
    ISSN 1897-9483 ; 0032-3772
    ISSN (online) 1897-9483
    ISSN 0032-3772
    DOI 10.20452/pamw.3417
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Regulation of Prothrombinase Activity by Protein S

    van't Veer, Cornelis / Butenas, Saulius / Golden, Neal J. / Mann, Kenneth G.

    Thrombosis and Haemostasis

    1999  Volume 81, Issue 07, Page(s) 80–87

    Abstract: The independent effect of protein S as prothrombinase inhibitor has been proposed to depend ... of protein S (300 nM) equilibrated with the prothrombinase components (factor Va, factor Xa, phospholipid ... cause a profound inhibition at low phospholipid concentrations (~0.2 μM). This inhibition by protein S ...

    Abstract The independent effect of protein S as prothrombinase inhibitor has been proposed to depend on binding to both coagulation factors Va and factor Xa or on the binding to phospholipid thereby limiting the phospholipid available for prothrombinase activity. In this study we show that plasma concentrations of protein S (300 nM) equilibrated with the prothrombinase components (factor Va, factor Xa, phospholipid) cause a profound inhibition at low phospholipid concentrations (~0.2 μM). This inhibition by protein S of prothrombinase activity is abrogated with increasing phospholipid concentrations. Modeling of the effect of protein S on prothrombinase based only on the reported affinity of protein S for phospholipids (K d ~ 10 -8 M) in an equilibrium model (Clotspeed), predicted the experimentally obtained thrombin generation rates at low phospholipid in the presence of protein S based on the diminished available phospholipid binding sites for the prothrombinase components. Consistently, initial rates of prothrombinase activity are already maximally inhibited when protein S is preincubated with the phospholipid prior to the addition of factor Xa, factor Va and pro-thrombin. The results indicate that the order of addition of prothrombinase components and the availability of phospholipid may have a profound influence on observed effects of protein S on prothrombinase activity. All prothrombinase components (factor Xa, factor Va, phospholipid) become available during the course of the physiological thrombin generation. The effect of protein S was therefore studied on tissue factor-induced, platelet-dependent thrombin generation. Protein S delayed and inhibited the rate of thrombin generation of tissue factor-induced thrombin formation when surface is provided at physiologic concentrations using isolated platelets (2 × 10 8 /ml). In contrast, protein S hardly affected thrombin generation in this model when platelets were pre-activated with collagen. Furthermore, the observed effects of addition of protein C and thrombomodulin in the absence or presence of protein S on tissue factor-induced, platelet-dependent thrombin generation, indicate that protein S and protein C may cooperate in the regulation of prothrombinase activity through independent mechanisms.
    Language English
    Publishing date 1999-01-01
    Publisher Schattauer GmbH
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 518294-3
    ISSN 2567-689X ; 0340-6245
    ISSN (online) 2567-689X
    ISSN 0340-6245
    DOI 10.1055/s-0037-1614633
    Database Thieme publisher's database

    More links

    Kategorien

  5. Article ; Online: Sex differences in the purinergic 2 receptor mediated blood pressure response to treadmill exercise in rats with simulated peripheral artery disease.

    Butenas, Alec L E / Flax, Joseph S / Carroll, Raimi J / Chuwonganant, C Shane / Baranczuk, Ashley M / Copp, Steven W

    American journal of physiology. Regulatory, integrative and comparative physiology

    2024  

    Abstract: We investigated the role played by ATP sensitive purinergic 2 (P2) receptors in evoking the pressor response to treadmill exercise in male and female rats with and without femoral arteries that were ligated for ~72 hours to induce simulated peripheral ... ...

    Abstract We investigated the role played by ATP sensitive purinergic 2 (P2) receptors in evoking the pressor response to treadmill exercise in male and female rats with and without femoral arteries that were ligated for ~72 hours to induce simulated peripheral artery disease (PAD). We hypothesized that PPADS (P2 receptor antagonist, 10 mg i.v.) would reduce the pressor response to four minutes of treadmill exercise (15 m×min
    Language English
    Publishing date 2024-03-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603839-6
    ISSN 1522-1490 ; 0363-6119
    ISSN (online) 1522-1490
    ISSN 0363-6119
    DOI 10.1152/ajpregu.00010.2024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Sex-dependent attenuating effects of capsaicin administration on the mechanoreflex in healthy rats.

    Butenas, Alec L E / Ishizawa, Rie / Rollins, Korynne S / Mizuno, Masaki / Copp, Steven W

    American journal of physiology. Heart and circulatory physiology

    2023  Volume 325, Issue 2, Page(s) H372–H384

    Abstract: ... the pressor and renal SNA (RSNA) response to 30 s of 1 Hz rhythmic hindlimb muscle stretch (a model ...

    Abstract Stimulation of mechanically sensitive channels on the sensory endings of group III and IV thin fiber muscle afferents activates the mechanoreflex, which contributes to reflex increases in sympathetic nerve activity (SNA) and blood pressure during exercise. Accumulating evidence suggests that activation of the nonselective cation channel transient receptor potential vanilloid-1 (TRPV1) on the sensory endings of thin fiber afferents with capsaicin may attenuate mechanosensation. However, no study has investigated the effect of capsaicin on the mechanoreflex. We tested the hypothesis that in male and female decerebrate, unanesthetized rats, the injection of capsaicin (0.05 µg) into the arterial supply of the hindlimb reduces the pressor and renal SNA (RSNA) response to 30 s of 1 Hz rhythmic hindlimb muscle stretch (a model of isolated mechanoreflex activation). In male rats (
    MeSH term(s) Rats ; Male ; Animals ; Muscle Contraction ; Muscle, Skeletal ; Capsaicin/pharmacology ; Rats, Sprague-Dawley ; Reflex ; Blood Pressure ; Hindlimb
    Chemical Substances Capsaicin (S07O44R1ZM)
    Language English
    Publishing date 2023-06-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 603838-4
    ISSN 1522-1539 ; 0363-6135
    ISSN (online) 1522-1539
    ISSN 0363-6135
    DOI 10.1152/ajpheart.00237.2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Activated factor XI is associated with increased factor VIIa - Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes.

    Paszek, Elżbieta / Pociask, Elżbieta / Ząbczyk, Michał / Butenas, Saulius / Undas, Anetta

    European journal of clinical investigation

    2022  Volume 52, Issue 12, Page(s) e13857

    Abstract: Background: Coronary artery disease (CAD) is associated with a prothrombotic tendency including increased factor (F) VIIa-antithrombin (FVIIa-AT) complexes, a measure of tissue factor (TF) exposure, and activated FXI (FXIa). We investigated whether ... ...

    Abstract Background: Coronary artery disease (CAD) is associated with a prothrombotic tendency including increased factor (F) VIIa-antithrombin (FVIIa-AT) complexes, a measure of tissue factor (TF) exposure, and activated FXI (FXIa). We investigated whether increased FVIIa-AT complexes are associated with FXIa and active TF and if major adverse clinical outcomes are predicted by the complexes in CAD.
    Methods: In 120 CAD patients, we assessed FVIIa-AT complex concentrations and the presence of circulating FXIa and active TF. Levels of 8-iso-prostaglandin F2α (8-iso-PGF2α), interleukin-6, high-sensitivity C reactive protein, prothrombin fragment 1 + 2, and free Tissue Factor Pathway Inhibitor were determined. Myocardial infarction (MI), ischemic stroke, systemic thromboembolism (SE), and cardiovascular (CV) death were recorded separately and as a composite endpoint, during follow-up.
    Results: FVIIa-AT complexes were positively associated with current smoking and multivessel CAD. Elevated FVIIa-AT complexes characterized patients with circulating FXIa and/or active TF in association with increased plasma isoprostanes but not with thrombin generation or inflammatory markers. During a median follow-up of 106 months (interquartile range 95-119), high baseline levels of FVIIa-AT complexes predicted ischemic stroke/SE (HR 4.61 [95% CI 1.48-18.42]) and a composite endpoint of MI, stroke/SE, and CV death (HR 7.47 [95% CI 2.81-19.87]).
    Conclusions: This study is the first to show that high FVIIa-AT complexes characterize advanced CAD patients with detectable FXIa and active TF, which is, in part, driven by oxidative stress. High FVIIa-AT complexes were associated with the risk of ischemic stroke/SE during long-term follow-up, highlighting the need for effective antithrombotic agents in CAD.
    MeSH term(s) Humans ; Factor XIa/metabolism ; Factor VIIa ; Antithrombins ; Coronary Artery Disease ; Antithrombin III ; Thromboplastin/metabolism ; Anticoagulants ; Myocardial Infarction ; Ischemic Stroke
    Chemical Substances Factor XIa (EC 3.4.21.27) ; Factor VIIa (EC 3.4.21.21) ; Antithrombins ; Antithrombin III (9000-94-6) ; Thromboplastin (9035-58-9) ; Anticoagulants
    Language English
    Publishing date 2022-08-29
    Publishing country England
    Document type Journal Article
    ZDB-ID 186196-7
    ISSN 1365-2362 ; 0014-2972 ; 0960-135X
    ISSN (online) 1365-2362
    ISSN 0014-2972 ; 0960-135X
    DOI 10.1111/eci.13857
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Comparison of natural and recombinant tissue factor proteins: new insights.

    Butenas, Saulius

    Biological chemistry

    2013  Volume 394, Issue 7, Page(s) 819–829

    Abstract: Tissue factor (TF), an initiator of blood coagulation in vivo, is expressed in a variety of cells. Sufficient natural TF has been isolated to clone and express recombinant proteins ranging from full-length TF to its extracellular domain. Because of the ... ...

    Abstract Tissue factor (TF), an initiator of blood coagulation in vivo, is expressed in a variety of cells. Sufficient natural TF has been isolated to clone and express recombinant proteins ranging from full-length TF to its extracellular domain. Because of the limited availability of natural TF, recombinant proteins have been used as surrogates. Despite the differences in their post-translational modifications, it has been accepted that membrane-anchored recombinant TFs are quite similar to the natural TF. Recent studies, however, have shown that post-translational modifications play an important role in TF-triggered thrombin generation.
    MeSH term(s) Blood Coagulation/genetics ; Blood Coagulation/physiology ; Factor VIIa/metabolism ; Humans ; Protein Processing, Post-Translational ; Recombinant Proteins/genetics ; Recombinant Proteins/metabolism ; Thrombin/metabolism ; Thromboplastin/genetics ; Thromboplastin/metabolism
    Chemical Substances Recombinant Proteins ; Thromboplastin (9035-58-9) ; Factor VIIa (EC 3.4.21.21) ; Thrombin (EC 3.4.21.5)
    Language English
    Publishing date 2013-07
    Publishing country Germany
    Document type Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1334659-3
    ISSN 1437-4315 ; 1431-6730 ; 1432-0355
    ISSN (online) 1437-4315
    ISSN 1431-6730 ; 1432-0355
    DOI 10.1515/hsz-2012-0350
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.

    Paszek, Elżbieta / Malinowski, Krzysztof P / Ząbczyk, Michał / Butenas, Saulius / Undas, Anetta

    European journal of clinical investigation

    2023  Volume 53, Issue 9, Page(s) e14007

    Abstract: Introduction: Patients with coronary artery disease (CAD) display a prothrombotic fibrin clot phenotype, involving low permeability and resistance to lysis. The determinants of this phenotype remain elusive. Circulating tissue factor (TF) and activated ... ...

    Abstract Introduction: Patients with coronary artery disease (CAD) display a prothrombotic fibrin clot phenotype, involving low permeability and resistance to lysis. The determinants of this phenotype remain elusive. Circulating tissue factor (TF) and activated factor XI (FXIa) are linked to arterial thromboembolism. We investigated whether detectable active TF and FXIa influence fibrin clot properties in CAD.
    Methods: In 118 CAD patients (median age 65 years, 78% men), we assessed Ks, an indicator of clot permeability, and clot lysis time (CLT) in plasma-based assays, along with the presence of active TF and FXIa. We also analysed proteins involved in clotting and thrombolysis, including fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and thrombin activatable thrombolysis inhibitor (TAFI). During a median 106 month (interquartile range 95-119) follow-up, myocardial infarction (MI), stroke, systemic thromboembolism (SE) and cardiovascular (CV) death were recorded.
    Results: Circulating TF and FXIa, detected in 20.3% and 39.8% of patients, respectively, were associated with low Ks and prolonged CLT. Solely FXIa remained an independent predictor of low Ks and high CLT on multivariable analysis. Additionally, fibrinogen and PAI-1 were associated with low Ks, while PAI-1 and TAFI-with prolonged CLT. During follow-up low Ks and prolonged CLT increased the risk of MI and the latter also a composite endpoint of MI, stroke/SE or CV death.
    Conclusions: To our knowledge, this study is the first to show that circulating FXIa is associated with prothrombotic fibrin clot properties in CAD, suggesting additional mechanisms through which FXIa inhibitors could act as novel antithrombotic agents in CAD.
    MeSH term(s) Humans ; Fibrin ; Factor XIa ; Plasminogen Activator Inhibitor 1 ; Coronary Artery Disease ; Thrombosis ; Fibrinolysis ; Fibrin Clot Lysis Time ; Thromboembolism ; Fibrinogen ; Stroke
    Chemical Substances Fibrin (9001-31-4) ; Factor XIa (EC 3.4.21.27) ; Plasminogen Activator Inhibitor 1 ; Fibrinogen (9001-32-5)
    Language English
    Publishing date 2023-04-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 186196-7
    ISSN 1365-2362 ; 0014-2972 ; 0960-135X
    ISSN (online) 1365-2362
    ISSN 0014-2972 ; 0960-135X
    DOI 10.1111/eci.14007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Tissue factor structure and function.

    Butenas, Saulius

    Scientifica

    2012  Volume 2012, Page(s) 964862

    Abstract: Tissue factor (TF) is an integral membrane protein that is essential to life. It is a component of the factor VIIa-TF complex enzyme and plays a primary role in both normal hemostasis and thrombosis. With a vascular injury, TF becomes exposed to blood ... ...

    Abstract Tissue factor (TF) is an integral membrane protein that is essential to life. It is a component of the factor VIIa-TF complex enzyme and plays a primary role in both normal hemostasis and thrombosis. With a vascular injury, TF becomes exposed to blood and binds plasma factor VIIa, and the resulting complex initiates a series of enzymatic reactions leading to clot formation and vascular sealing. Many cells, both healthy, and tumor cells, produce detectable amounts of TF, especially when they are stimulated by various agents. Despite the relative simplicity and small size of TF, there are numerous contradictory reports about the synthesis and presentation of TF on blood cells and circulation in normal blood either on microparticles or as a soluble protein. Another subject of controversy is related to the structure/function of TF. It has been almost commonly accepted that cell-surface-associated TF has low (if any) activity, that is, is "encrypted" and requires specific conditions/reagents to become active, that is, "decrypted." However there is a lack of agreement related to the mechanism and processes leading to alterations in TF function. In this paper TF structure, presentation, and function, and controversies concerning these features are discussed.
    Language English
    Publishing date 2012-12-26
    Publishing country Egypt
    Document type Journal Article ; Review
    ZDB-ID 2672321-9
    ISSN 2090-908X
    ISSN 2090-908X
    DOI 10.6064/2012/964862
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top